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Tumor Necrosis Factor-Related Apoptosis-Inducing
Ligand on NK Cells Protects From Hepatic
Ischemia-Reperfusion Injury
Rene´ Fahrner,1,2 Markus Trochsler,1,2 Nadia Corazza,3 Nadine Graubardt,2 Adrian Keogh,1,2
Daniel Candinas,1,2 Thomas Brunner,4 Deborah Stroka,1,2 and Guido Beldi1,2,5
Background. Ischemia-reperfusion injury (IRI) significantly contributes to graft dysfunction after liver transplan-
tation. Natural killer (NK) cells are crucial innate effector cells in the liver and express tumor necrosis factor-related
apoptosis-inducing ligand (TRAIL), a potent inducer of hepatocyte cell death. Here, we investigated if TRAIL ex-
pression on NK cells contributes to hepatic IRI.
Methods. The outcome after partial hepatic IRI was assessed in TRAIL-null mice and contrasted to C57BL/6J wild-
type mice and after NK cell adoptive transfer in RAG2/common gamma-null mice that lack T, B, and NK cells. Liver
IRI was assessed by histological analysis, alanine aminotransferase, hepatic neutrophil activation by myeloperoxidase
activity, and cytokine secretion at specific time points. NK cell cytotoxicity and differentiation were assessed in
vivo and in vitro.
Results. Twenty-four hours after reperfusion, TRAIL-null mice exhibited significantly higher serum transaminases,
histological signs of necrosis, neutrophil infiltration, and serum levels of interleukin-6 compared to wild-type ani-
mals. Adoptive transfer of TRAIL-null NK cells into immunodeficient RAG2/common gamma-null mice was asso-
ciated with significantly elevated liver damage compared to transfer of wild-type NK cells. In TRAIL-null mice, NK
cells exhibit higher cytotoxicity and decreased differentiation compared to wild-type mice. In vitro, cytotoxicity
against YAC-1 and secretion of interferon gamma by TRAIL-null NK cells were significantly increased compared to
wild-type controls.
Conclusions. These experiments reveal that expression of TRAIL on NK cells is protective in a murine model of
hepatic IRI through modulation of NK cell cytotoxicity and NK cell differentiation.
Keywords: NK cells, Tumor necrosis factor-related apoptosis-inducing ligand, Hepatic ischemia-reperfusion injury,
NK cell maturation, Cytotoxicity.
(Transplantation 2014;97: 1102Y1109)
Hepatic ischemia-reperfusion injury (IRI) is characterizedby parenchymal inflammation associated with apoptosis
and necrosis of hepatocytes and sinusoidal endothelial cells,
thereby leading to liver graft dysfunction (1, 2). This process
is modulated by paracrine interactions with circulating non-
parenchymal inflammatory cells, including Kupffer cells,
dendritic cells, T cells, and natural killer (NK) cells (3). In the
human liver, NK cells are the main innate lymphoid cell
population and interact with non-parenchymal and paren-
chymal cells through activating and inhibitory receptors,
thereby shaping innate immune responses through the main
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effector functions that consist of cytotoxicity and cytokine
secretion (4Y7).
Tumor necrosis factor apoptosis-inducing ligand (TRAIL,
Apo2L) is a type II membrane bound TNF family ligand,
which was originally identified on the basis of sequence
homology to Fas ligand (FasL) and tumor necrosis factor
(TNF) (8, 9). Although TRAIL is constitutively expressed on
mRNA level in a wide variety of normal tissues, the expres-
sion of functional TRAIL protein appears to be rather restric-
ted to immune cells, including NK cells, T cells, monocytes,
dendritic cells, and neutrophils (10Y16). Interestingly, he-
patic NK cells express TRAIL whereas mature splenic NK
cells are TRAIL negative (17). Furthermore, the expression
of TRAIL on hepatic NK cells seems to critically modulate
NK cell-induced hepatocyte cell death (18).
In this study, we explored the role of TRAIL on NK
cells in a murine model of partial hepatic IRI. We show an
up-regulation of TRAIL post-IRI and a significant elevation
of liver injury after warm liver ischemia in TRAIL-null mice
compared to wild-type mice. In addition, we observed in-
creased recruitment of granulocytes into the liver in TRAIL-
null mice in response to IRI and elevated cytotoxicity of NK
cells from TRAIL-null mice in vivo and in vitro. The im-
portance of TRAIL expression on NK cells during IRI was
confirmed by adoptive transfer experiments of wild-type
and mutant TRAIL-null NK cells into RAG2/common gamma-
null mice that lack B, T, and NK cells. These results support
a novel role of TRAIL and NK cells in the regulation of liver
damage induced by IRI.
RESULTS
Deletion of TRAIL is Associated With
Increased Hepatic IRI
Hepatic injury in response to IR was assessed in
TRAIL-null and wild-type mice. All animals survived the
FIGURE 1. Liver injury and degree of liver necrosis is increased in TRAIL-null compared to wild-type mice after partial
hepatic IRI. In wild-typemice, hepatic expression of TRAILwas significantly increased at 24 hrof partial hepatic IRI compared
to untreated animals (A). Assessment of liver injury by serum ALT levels 24 hr after hepatic IRI showed significantly higher
levels in TRAIL-null mice compared towild-type mice (B). Four days after IRI, the extent of necrotic tissue in TRAIL-null mice
was significantly higher compared to wild-type mice (C). Representative images of livers with HE staining at 50 magni-
fication (wild-typemice in D, TRAIL-null mice in E). Mean valuesTSD are shown, Mann-Whitney test, n=10 animals per group.
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postoperative course until harvest at indicated time points.
IRI resulted in a significant increase of TRAIL mRNA ex-
pression in the livers of wild-type animals compared non-
injured controls (Fig. 1A). Liver injury was assessed by ala-
nine aminotransferase (ALT) measurements and increased
6 hr of reperfusion in wild-type and TRAIL-null animals
(Fig. 1B). ALT levels declined after 24 hr in both groups;
however, they were significantly higher in TRAIL-null com-
pared to wild-type mice (Fig. 1B). TRAIL-null mice showed
significantly higher histological signs of necrotic liver tis-
sue compared to wild-type mice 4 days after reperfusion
(Fig. 1CYE).
Next, we examined the extent of neutrophil activation
and infiltration by MPO activity and Gr-1 positive immu-
noreactivity. There was significantly higher MPO activity in
the livers of TRAIL-null compared to wild-type mice (Fig. 2A).
Correspondingly, there was a significantly higher number of
Gr-1 positive cells in TRAIL-null mice 24 hr after reperfu-
sion as assessed by immunohistochemistry (Fig. 2B-F).
TRAIL-null mice showed a significant increase of the pro-
inflammatory acute phase cytokine IL-6 3 hr after partial
hepatic ischemia (Fig. 3A), whereas TNF alpha (Fig. 3B),
IL-1 beta (Fig. 3C), and IL-5 (Fig. 3D) did not differ sig-
nificantly between the groups.
TRAIL Deficiency in NK Cells is Associated
With Increased Liver Injury and Oxidative
Burst After Partial Hepatic Ischemia
Next, we questioned the impact of NK cells and more
specifically TRAIL expression on NK cells during hepatic IRI.
Adoptive transfer of TRAIL-null and wild-type NK cells into
RAG2/common gamma-null recipients was performed. Adop-
tive transfer of TRAIL-null NK cells was associated with sig-
nificantly elevated liver injury compared to wild-type NK cells
FIGURE 2. Neutrophil infiltration and activation is increased in TRAIL-null compared towild-typemice after partial hepatic
IRI. Myeloperoxidase activity in the liver was significantly higher in TRAIL-null mice compared to wild-type mice after
hepatic IRI (A). Twenty-four hours after IRI, a significantly higher influx of Gr-1 positive cells was detectable in livers from
TRAIL-null mice compared to wild-type mice (B, mean valuesTSD, Mann-Whitney test, n=8 animals per group). Represen-
tative images of livers with immunostaining for Gr-1 at50 (C, D) and400 (E, F) magnification (wild-type in C and E, TRAIL-
null in D and F).
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(Fig. 4A). Furthermore, MPO levels and expression of Gr-1
positive cells in the ischemic liver lobe were significantly
increased after transfer of TRAIL-null NK cells compared to
wild-type NK cells (Fig. 4B and C).
Cytotoxicity is Increased in NK Cells in
TRAIL-Null Mice After IRI
Cytotoxicity and cytokine secretion of NK cells and
depend on the state of differentiation (5, 19). Expression of
the cytotoxic granule protein CD107a (LAMP-1) on the cell
surface is a marker of lysosomal degranulation and cyto-
toxicity in NK cells. CD107a positive NK cells were signifi-
cantly increased in non-ischemic liver lobes in mice null for
TRAIL compared to wild-type mice (Fig. 5A). After partial
hepatic IRI, cytotoxic CD107a positive NK cells were further
increased in TRAIL-null livers compared to wild-type livers
(Fig. 5A). NK cell cytotoxicity in vitro was assessed using
NK cell-sensitive YAC-1 target cells. Sorted TRAIL-null NK
(NK1.1 positive, CD3 negative) cells showed significantly ele-
vated cytotoxicity compared to wild-type NK cells (Fig. 5B).
Decreased Levels of Immature NK Cells and
Increased Secretion of Interferon Gamma
Secretion by TRAIL-Null NK Cells
The surface marker CD27, a member of the TNF-
receptor superfamily, allows to distinguish mature (CD27
low) from immature (CD27 high) NK cells in mice. Frac-
tions of mature (CD27 low) NK cells were significantly de-
creased in livers of TRAIL-null mice compared to wild-type
mice under basal conditions and after hepatic IRI (Fig. 5C
and D). Further analysis of other subsets of lymphocytes
revealed no differences in CD3 positive lymphocytes and frac-
tions of NKT (Figure S1, SDC, http://links.lww.com/TP/A964).
Interferon gamma secretion from sorted NK cells in vitro
was significantly higher in TRAIL-null NK cells compared
to wild-type NK cells in response to IL-12 and IL-18 stimu-
lation (Fig. 5E).
DISCUSSION
This study investigated the role of TRAIL on NK cells
during partial hepatic IRI. Hepatic injury was significantly
increased in TRAIL-null mice in comparison to wild-type
mice. Adoptive transfer of TRAIL-null NK cells into RAG2/
common gamma-null mice was also associated with increased
liver injury, emphasizing the importance of TRAIL on NK
cells in tissue protection during IRI.
Warm ischemia of the liver leads to damage of hepato-
cytes and subsequent increase of serum ALT levels in response
to release of oxygen-free radicals, cytokines, and chemokines,
which then activate cascades of the pro-inflammatory im-
mune response (20). Interestingly, parameters of tissue dam-
age and inflammation were elevated in TRAIL-null mice. In
response to these processes, the acute phase cytokine IL-6
that is secreted from parenchymal and non-parenchymal
hepatic cells during liver injury (21Y23) again was increased
in TRAIL-null mice. Interestingly, hepatic TRAIL expression
in wild-type mice was per se increased after IRI compared to
untreated mice. This fact indicates an up-regulation of he-
patic TRAIL expression during liver ischemia and reperfu-
sion and might constrain further liver damage by clearing,
for example, apoptotic and necrotic cells and probably blocking
NK cells activation as seen in TRAIL-null mice.
NK cells are cytotoxic lymphocytes of the innate im-
mune system and can recognize stressed cells in the absence
of antibodies or major histocompatibility complex (MHC)
class 1 (24). In our study, TRAIL deficiency on NK cells was
associated with elevated cytotoxicity after NK-cell stimula-
tion in vitro and in vivo. Previous studies revealed that
FIGURE 3. Increased serum levels of IL-6 in TRAIL-null mice. Serum cytokine levels were measured after 3 hr of re-
perfusion in TRAIL-null and wild-type mice. IL-6 levels were significantly increased in TRAIL-null mice compared to wild-
type mice (A), whereas TNF alpha, IL-1 beta, and IL-5 were not significantly different between the groups (BYD). Mean
valuesTSD, Mann-Whitney test, n=8 animals per group.
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injury and repair is modulated by NK cells via lysis of stressed
or infected cells, thereby modulating injury and repair (25).
We show that NK cell-dependent exocytosis of cytotoxic
granules occurs on the cell surface through the exposure of the
endosomal membrane protein CD107a (LAMP-1) (16, 26).
There is evidence that NK cells promote hepatic IRI in
a phase-specific pattern (27, 28). As shown in our study,
TRAIL seems not just to impact on cytotoxicity but also on
secretion of interferon gamma by NK cells. Previously, we
have shown a that dysfunctional NK cell-dependent secre-
tion of interferon gamma is associated reduced liver injury,
revealing the relevance of NK cells on cellular crosstalk during
IRI (29). Hepatic IRI is associated with increased levels of
interferons (29Y32). However, the secretion interferon gam-
ma is rather associated with a local acute phase reaction and
is not sufficient to maintain hepatic IRI alone (33). Local
alterations of interferon gamma seem to be sufficient to
explain the observed phenotype as systemic levels of inter-
feron gamma were too low for detection. Elevated secretion
of interferon gamma as observed in our experiments is a
potential forward feedback for the expression of TRAIL on
NK cells as shown in other models (14).
The lower frequency of mature NK cells in TRAIL-null
mice potentially results from decreased activation and mo-
bilization of hepatic NK cells. TRAIL expression on NK and
other cells such as dendritic or Kupffer cells potentially modu-
lates NK cell mobilization via auto- and paracrine interactions
in response to an inflammatory stimulus and presence of
danger associated molecular patterns (DAMPs) as described
in other models (34). Previous studies revealed that an ex-
cessive immune response may be limited through TRAIL
and required direct interactions with resident or circulating
antigen presenting cells (35, 36). TRAIL expression on in-
nate lymphoid cells has been shown to be protective in IRI
but is associated with elevated injury in a model of conca-
navalin A-mediated liver damage (37). However, in hepatic
IRI mainly paracrine interactions and DAMPs activate NK
cell activation, whereas the lectin concanavalin A mainly
activates NKT cells rather than NK cells and thereby con-
tributes to hepatocyte apoptosis in a different manner. These
results are supported by recent findings in which we showed
that interactions of NK cells with Kupffer cells are protective
in a model of partial hepatectomy (19).
In conclusion, these experiments demonstrate that
the expression of TRAIL on NK cells is required to limit
liver injury in a model of hepatic IRI. TRAIL controls hepatic
NK-cell cytotoxicity, cytokine secretion, and the recruitment
of NK cells to the liver with consecutive reduced influx of
granulocytes and hepatocellular necrosis and injury.
MATERIALS AND METHODS
All research protocols were carried out in accordance with the National
Institutes of Health guidelines for the care and use of experimental animals
and approval of the Animal Care Committee of the Canton Bern, Switzerland.
Animal Preparation and Experimental Setting
Experiments were performed using mice on the C57BL/6J background.
Wild-type C57BL/6J and TRAIL-null (TRAILj/j) mice were bred and main-
tained in the Central Animal Facility of the University of Bern, Switzerland
(38), Rag2/common gamma-null (RAG2cFj/j) mice were purchased from
Taconic (Germantown, NY). Animals were housed with a 12-hr light-dark
FIGURE 4. TRAIL expression on NK cells mediates liver
injury. Adoptive transfer of wild-type and TRAIL-null NK cells
was performed into Rag2/common gamma-null mice that lack
B, T, and NK cells. Liver injury, myeloperoxidase activity, and
Gr-1 positive cells in liver section were assessed 24 hr after
hepatic IRI. Liver injury was significantly increased after
adoptive transfer of TRAIL-null NK cells compared to wild-
type NK cells (A). Myeloperoxidase activity in the liver
and influx ofGr-1 positive cellswas significantly higher after
adoptive transfer of TRAIL-null NK cells compared to wild-
type NK cell adoptive transfer (B, C). Mean valuesTSD,
Mann-Whitney test, n=6Y8 animals per group.
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cycle at 22-C. All operations were performed in animals at the age of 8 to
12 weeks on a warming plate to maintain body temperature. The abdomi-
nal contents were rinsed during the operation with saline to avoid drying-
out. Buprenorphin (Reckitt Benckiser AG, Switzerland) was administered
subcutaneously after 6 hr for postoperative analgesia and in further post-
operative course depending on the general condition of the animals. Blood
samples were taken after 3 and 6 hr of reperfusion. At specific time points,
mice were anesthetized, blood was taken from the inferior vena cava, and
liver lobes were removed and further processed.
Surgical Procedures
Under general anesthesia with xylazine 10 mg/mL (Graeub AG, Switzerland),
ketamine 80 mg/kg (Pfizer AG, Switzerland), and heparin 200 U/kg (Bichsel
AG, Switzerland), an oblique laparotomy was performed and the hepatic
artery and portal vein of the left liver lobe were temporarily clamped for
60 min under control of body temperature. Hepatic veins were not clamped.
After removal of the clamp, the abdomen was closed in two layers and
buprenorphin was administered subcutaneously for analgesia.
Rag2/common gamma-null mice (Taconic, Denmark) were used for adop-
tive transfer experiments by injecting a total of 106 sorted splenic NK (NK1.1
positive, CD49b positive, CD3 negative) cells in 100 KL of phosphate buff-
ered saline (Invitrogen Life Technologies, Darmstadt, Germany) into the
saphenous vein under intraperitoneal general anesthesia using medetomidine
0.5 mg/kg (Graeub AG, Switzerland), climazolamum 5 mg/kg (Graeub AG,
Switzerland), and fentanyl 0.05 mg/kg (Janssen-Cilag, Switzerland). Surgery
was performed 6 days after adoptive transfer as described above.
Immunohistochemical Analysis of the Liver
Fresh liver tissue was fixed overnight in 4% paraformaldehyde. For
hematoxylin-eosin (HE) staining, sections were deparaffinized with xylol
and then counterstained with HE. The degree of liver necrosis was assessed
in HE-stained liver tissue (four high-power fields, 40 times magnification)
after 4 days of liver reperfusion using a computerized program (ImageJ).
For granulocyte staining, slides of paraformaldehyde-fixed tissue were
dewaxed, rehydrated, and blocked by endogenous peroxidase 3% H2O2.
After antigen retrieval, first anti-Gr-1 antibody (Gr-1 anti-mouse Ly-6G,
FIGURE 5. Deletion of TRAIL on NK cells impacts on effector function and maturation of NK cells in vivo and in vitro. Three
hours after hepatic IRI, the percentage of cytotoxic CD107a positive cells was significantly increased in TRAIL-null mice
compared to wild-type mice (A). In vitro, cytotoxicity of sorted TRAIL-null NK cells against YAC-1 cells was significantly
increased compared towild-type NK cells (B). The fraction ofmatureCD27 low in non-ischemic liver lobes of TRAIL-null mice
was reduced compared towild-typemice (C). In addition, the decrease of CD27 lowNK cells after induction of partial hepatic
ischemia was higher in TRAIL-deficient mice compared to wild-type mice, suggesting a change of NK-cell mobilization
during hepatic ischemia (C, D). Secretion of interferon gamma in response to stimulation with IL-12 and IL-18 was signifi-
cantly higher in TRAIL-null NK cells compared to wild-type NK cells (E). Mean valuesTSD, Mann-Whitney test, n=8 animals
per group.
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eBioscience, #4-5931-85) and second biotinylated anti-rat antibody (#E0468
Dako, Denmark) were applied. After incubation of the tissue sections with
DAB, slides were counterstained with hematoxylin (H-51275; Sigma-Aldrich
Chemie GmbH, Steinheim, Germany). Finally, Gr-1 positive and negative
areas were measured in each animal on four high-power fields of liver tissue
with 40 times magnification 24 hr after liver reperfusion using a comput-
erized program (ImageJ).
Measurement of Liver Injury
ALT levels in the serum were measured 6 and 24 hr after liver reperfu-
sion by a photometric UV test measuring the oxidation of NADH to NAD
(Modular Analytics EVO, P800; Roche, Germany).
Measurements of Cytokine Levels by
Enzyme-Linked Immunosorbent Assay
The serum concentrations of tumor necrosis factor (TNF) alpha, inter-
leukin (IL)-6, IL-1 beta, and IL-5 were examined after 3 hr of liver reper-
fusion by enzyme-linked immunosorbent assay using immunoassay kits
(PeproTech Inc., Rocky Hill, NJ) according to the recommended protocol.
Hepatic Neutrophil Detection by
Myeloperoxidase Assay
Myeloperoxidase assay was carried out as previously described (39).
Briefly, liver samples were thawed, 50 mg of tissue was weighed out and
homogenized in 1 mL of 20 mM phosphate buffer using a TissueLyser
(Qiagen) 2 min at 20 Hz, centrifuged at 10,000g for 10 min, and the pel-
let was resuspended in 50 mM phosphate buffer (pH 6.0) containing
0.5% hexadecyltrimethyl ammonium bromide. The samples were then
freeze-thawed four times using liquid nitrogen followed by a 40-sec soni-
cation, centrifuged at 10,000g for 10 min, and the supernatant was used for
the MPO assay. The assay mixture contained 10 HL of the sample, 25 HL
3,3¶5,5-tetramethylbenzidine (final concentration 1.6 mM), 25 HL H2O2 in
80 mM phosphate buffer (pH 5.4, final concentration H2O2 0.3 mM), and
40 HL of 50 mM phosphate buffer (pH 6.0) containing 0.5% hexadecyltrimethyl
ammonium bromide. The mixture was incubated at 37-C for 2 min,
stopped with the addition of 1 M HCl, and the absorbance was measured
at 450 nm.
Quantitative TaqMan PCR
RNA was isolated from snap-frozen ischemic liver samples by Trizol
Reagent according to the manufacturer’s protocol (Life Technologies). cDNA
was synthesized by using Omniscript RT kit 200 (Cat. No. 205113; Qiagen).
mRNA of TRAIL in ischemic livers was analyzed by qRT-PCR (ABI 7900, SDS
2.3 software), and primers and probes sequences were ready to use from
Applied Biosystems (Tnfsf10, #Mm00437174_m1, Rotkreuz, Switzerland).
As reference gene control (RG), beta actin (#Mm00607939_s1; Rotkreuz,
Switzerland) was used. The relative changes in mRNA were calculated with
the $$Ct method, whereas Ct values of target gene expression (TG) were
calculated relative to the RG using the following formula: $CtTG=CtTGjCtRG.
Experimental groups (TG) were normalized to control group (CG): $$Ct=$
CtTGI
$CtCG, fold increase=2
j$$Ct.
Antibodies
The following antibodies were used for flow cytometry analysis: anti-mouse
NK1.1 (APC), CD107a (PE), CD3 (FITC), CD4 (PE), CD27 (PE-Cy7), CD49b
(PE-Cy7), CD8 (PE), and CD19 (PE), which were purchased from eBioscience.
A SORP LSRII cytometer (BD Bioscience) was used for flow cytometry
analysis, and data were analyzed using FlowJo software. A FACSAria III
cell sorter (BD Bioscience) was used for NK cell-sorting experiments.
Purification of Liver Mononuclear Cells
and Splenic NK Cells
Ischemic and non-ischemic liver lobes were excised during harvest
and passed through a 200G stainless steel mesh. After centrifugation of
the filtrate at 50g for 3 min, the supernatant was collected, the non-
parenchymal cell supernatant fraction was washed once and resuspended
in a 35% Percoll (GE Healthcare) solution, and overlaid on a 70% Per-
coll solution. After cell separation at 800g for 20 min, the interphase was
collected and the cells were stained with specific antibodies. Finally, cell
analysis was performed by flow cytometry. Spleens were excised and NK
cells were purified to perform adoptive transfer experiments, cytotoxicity,
and interferon gamma secretion assays. Depletion of CD4, CD8, and CD19
(all PE-labeled) positive cells was performed by using electromagnetic beads
following the manufacturer’s protocol (Miltenyi Biotec Inc., Auburn, CA).
The flow-through was labeled with NK1.1 (APC), CD49b (PECy7), and
CD3 (FITC) for sorting of NK1.1/CD49b positive CD3 negative NK cells
on a FACSAria III.
Cytotoxicity Assay
Sorted primary murine NK cells were used for a 4-hr 51Cr-release assay
using the NK cell-sensitive murine lymphoma cell line YAC-1 as target cells.
YAC-1 cells were radiolabeled with 500 mCi of 51Cr (PerkinElmer, NEZ03000)
per 500 HL cell suspension for 1 hr at 37-C. After washing, YAC-1 cells were
incubated for 1 hr at 37-C and then washed again. Isolated primary murine
NK cells were sorted by flow cytometry as described above. NK cells and
YAC-1 cells were mixed at a ratio of 1:20 in a U-bottom 96-well plate. After
incubation for 4 hr at 37-C and 5% CO2/air atmosphere, 10% Triton X-100
was added to each positive control. The release of 51Cr was measured in
the supernatant using a gamma counter (COBRA II; Packard S/N 404470)
and the specific lysis was calculated.
Interferon Gamma Secretion
Assay of NK Cells
Isolated and sorted splenic NK cells were plated in a 96-well plate. After
incubation with IL-12 and IL-18 (Sigma-Aldrich Chemie GmbH, Steinheim,
Germany) overnight, interferon gamma secretion was measured in the
supernatant using an immunoassay kit (PeproTech) according to the recom-
mended protocol.
Statistics
All data are expressed as geometric meansTstandard deviations. For sta-
tistical analysis, a nonparametric test (Mann-Whitney test) was used. Sta-
tistical analysis was performed with GraphPad Prism version 5.0 (GraphPad
Software, Inc., La Jolla, CA). Data with P less than 0.05 was considered as
statistically significant.
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